Bumper Offer - Urjas oil Just @ Rs. 1
Sporidex Redimix 250 Oral Suspension 30ml, a prescription drug, is manufactured in various forms such as Suspension. It is primarily used for the treatment of Bacterial Infections. Sporidex Redimix 250 Oral Suspension 30ml also has some secondary and off-label uses. These are listed below.
The right dosage of Sporidex Redimix 250 Oral Suspension 30ml depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Sporidex Redimix 250 Oral Suspension 30ml are Nausea or vomiting, Allergic reaction, Rash. Apart from the aforementioned side effects, Sporidex Redimix 250 Oral Suspension 30ml can also lead to other problems, which have been listed below. These side effects of Sporidex Redimix 250 Oral Suspension 30ml are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Sporidex Redimix 250 Oral Suspension 30ml's effect during pregnancy is Safe and Safe while nursing. In addition, Sporidex Redimix 250 Oral Suspension 30ml's effects on the liver, heart and kidney are discussed below in the Sporidex Redimix 250 Oral Suspension 30ml related warnings section.
Other contraindications of Sporidex Redimix 250 Oral Suspension 30ml have been discussed in the sections ahead.
Drug interactions for Sporidex Redimix 250 Oral Suspension 30ml have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Sporidex Redimix 250 Oral Suspension 30ml is safe while driving, and is addiction.
Sporidex Redimix 250 Oral Suspension 30ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Sporidex Redimix 250 Oral Suspension 30ml is used -
Severe
Moderate
Mild
Common
Is the use of Sporidex Redimix 250 Oral Suspension 30ml safe for pregnant women?
There are no side effects of Sporidex in pregnant women.
Is the use of Sporidex Redimix 250 Oral Suspension 30ml safe during breastfeeding?
Sporidex does not show any side effects in breastfeeding women.
What is the effect of Sporidex Redimix 250 Oral Suspension 30ml on the Kidneys?
Sporidex may have mild side effects on the kidneys.
What is the effect of Sporidex Redimix 250 Oral Suspension 30ml on the Liver?
Using Sporidex does not have any harmful effects on the liver.
What is the effect of Sporidex Redimix 250 Oral Suspension 30ml on the Heart?
You can take Sporidex without any fear of damage to the heart.
Sporidex Redimix 250 Oral Suspension 30ml should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Sporidex Redimix 250 Oral Suspension 30ml unless your doctor advises you to do so -
Is this Sporidex Redimix 250 Oral Suspension 30ml habit forming or addictive?
Forming a habit of Sporidex Redimix 250 Oral Suspension 30ml has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Sporidex Redimix 250 Oral Suspension 30ml will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Sporidex Redimix 250 Oral Suspension 30ml should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sporidex Redimix 250 Oral Suspension 30ml for mental disorders.
Interaction between Food and Sporidex Redimix 250 Oral Suspension 30ml
Taking Sporidex Redimix 250 Oral Suspension 30ml with food does not cause any problems.
Interaction between Alcohol and Sporidex Redimix 250 Oral Suspension 30ml
It is difficult to say anything about the effect of Sporidex Redimix 250 Oral Suspension 30ml and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300